601 Pennsylvania Ave. Washington D.C., U.S.A
Showing all 23 results
Up To $68 Billion / Annum. 10 Submarkets. 2 Scenarios.
More Than 270 COVID-19 Drugs & Vaccines Currently Under Development
Annual market up to $478 Billion*. Two Scenarios. 54 Reports in 1.
Market worth up to $91 billion per annum. 8 sub-reports
Cumulative 2020-2024 Market: $1.6 Trillion (scenario A); $2.2 Trillion (scenario B), 248 Sub-Markets. 5 Volumes.
Worth More Than* $24.5 Billion in 2021. 3 Submarkets. 2 Scenarios.
Worth More Than $82 Billion in 2021
Worth More Than* $300 Billion / Annum. 5 Submarkets. 2 Scenarios.
Up To* $30 Billion / Annum. 9 Submarkets. 2 Scenarios.
Cumulative 2020-2024 market $89 Billion (scenario B)
Cumulative 2020-2024 market $91 Billion (scenario B)
Cumulative 2020-2024 market $255 Billion (scenario B). The World 2nd Largest Market.
Cumulative 2020-2024 market $84 Billion (scenario B)
Cumulative 2020-2024 market $510 Billion (scenario B). World Largest Market.
Worth More Than $82 Billion in 2021
Cumulative 2020-2024 market $87 Billion (scenario B)
Market worth up to $91 billion per annum. 7 sub-reports
Cumulative 2020-2024 market $86 Billion (scenario B)
Cumulative 2020-2024 market $53 Billion (scenario B)
Market worth up to $91 billion per annum. 5 sub-reports
4 in-depth sub-reports